Odaily Planet Daily News: Bitcoin investment company Parataxis Holdings LLC announced that it has reached a final investment agreement worth 25 billion won with Bridge Biotherapeutics, Inc., which gives it control over the latter. After the transaction is completed, Bridge Biotherapeutics will be renamed Parataxis Korea and continue to be listed on the KOSDAQ, the Korean startup board market. The company is expected to announce more details about this transaction after holding a shareholders' meeting in August. (PRNewswire) Previously, it was reported that Parataxis Holdings LLC plans to go public through a merger with special purpose acquisition company SilverBox Corp IV, with both parties having signed a non-binding letter of intent.